Israeli study finds Pfizer booster vaccine protects against omicron.

Israeli researchers said on Saturday 11 December 2021 they found that a three-dose course of Pfizer and BioNTech’s COVID-19 vaccine provided significant protection against the new omicron variant.

The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant.

The study, carried out by Sheba Medical Center and the Health Ministry’s Central Virology Laboratory, compared the blood of 20 people who had received two vaccine doses five to six months earlier to the same number of individuals who had received a booster a month before.

The Israeli research follows a study from South Africa that found the Omicron variant can partially evade protection from two doses.

Source: www.reuters.com


No comments:

Post a Comment




Popular Posts

Blog Archive

Recent Posts